Physician profile
Michael C Ibe
NPI 1215291026
$17,542.95
in general payments reported to CMS, 2019-2025
37 companies · $2,853 in 2025
The $2,853 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $941 · 2021: $2,977 · 2022: $3,798 · 2023: $4,414 · 2024: $1,022 · 2025: $2,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,769 · Travel and Lodging: $2,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,768.96 |
| Travel and Lodging | $2,520.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,277.76 | 2023-2025 | Indigo System, Smart Coil |
| Medtronic, INC. | $3,599.07 | 2021-2024 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $2,118.41 | 2021-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abiomed | $928.48 | 2020-2025 | Impella |
| Shockwave Medical, INC | $637.01 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $602.04 | 2020-2025 | Bodyguardian, Watchman Flx, S-Icd System Magnet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $525.35 | 2019-2025 | Lifevest |
| Abbott Laboratories | $506.61 | 2020-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint |
| Astrazeneca Pharmaceuticals LP | $390.58 | 2019-2023 | Farxiga, Andexxa |
| Glaxosmithkline, LLC. | $380.78 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $341.67 | 2019-2025 | |
| Amarin Pharma, INC. | $328.69 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $315.90 | 2022-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $287.89 | 2019-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $284.86 | 2019-2020 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ibe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.